Skip to main content

Cambridge Innovation Capital — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

52
Companies
$1.8B
Total invested
$33.8M
Avg. check
35
Industries
Biotechnology 12Medical 8Life Science 6Therapeutics 6Health Care 5Software 5+29 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 52
Microbiotica
October 2026

Microbiotica develops microbiome-based medicines that use selected gut bacteria for the treatment of cancer and inflammatory bowel diseases.

Biopharma · Cambridge$47.9M Series C
Salience Labs
October 2026

Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning.

AI Infrastructure · Oxford$125.0M Series B
CMR Surgical
October 2026

CMR Surgical develops and manufactures robotic surgical systems to enhance precision and efficiency in minimally invasive surgery.

Health Care · Cambridge$400.0M Corporate Round
TRIMTECH Therapeutics
June 2026

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

Biotechnology · Cambridge$14.0M Seed
Undo
June 2026

Undo is a technology company that offers time travel debugging services for Linux.

Developer Tools · Cambridge$37.0M Private Equity
Storm Therapeutics
April 2026

Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.

Biotechnology · Cambridge$56.0M Series C
Trent AI
April 2026

Trent AI is an agentic AI safety platform that provides unnoticed, automatic protection for LLMs and AI processes.

Agentic AI · London$12.7M Seed
Immutrin
March 2026

Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.

Biotechnology · Cambridge$87.1M Series A
Nuclera
January 2026

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Biotechnology · Cambridge$12.0M Series C
T-Therapeutics
November 2025

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Biotechnology · Cambridge$32.0M Series A
Pretzel Therapeutics
July 2025

Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.

Biotechnology · WalthamVenture - Series Unknown
Sortera Bio
June 2025

Sortera Bio operates as a biotechnology company.

Biotechnology · Cambridge$10.2M Pre-Seed
Mosaic Therapeutics
April 2025

Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.

Biotechnology · CambridgeCorporate Round
PervasID
April 2025

PervasID is developing a high reliability

Developer Tools · Cambridge$264K Venture - Series Unknown
Cambridge GaN Devices
February 2025

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

Electronics · Cambridge$32.0M Series C
Forefront RF
November 2024

Forefront RF is a fabless semiconductor company.

Semiconductor · Cambridge$20.8M Series A
Epitopea
October 2024

Epitopea is a transatlantic cancer immunotherapeutics company.

Biotechnology · Cambridge$31.0M Seed
Riverlane
August 2024

Riverlane develops software solutions to harness the power of quantum computers for practical applications.

Computer · Cambridge$75.0M Series C
Secondmind
November 2023

Machine learning for automotive innovators

Artificial Intelligence (AI) · Cambridge$16.0M Venture - Series Unknown
Phosphor AI
August 2023

Phosphor AI provides personalized AI tutoring solutions for secondary education.

Education · Cambridge$2.5M Seed
Complement Therapeutics
April 2023

Complement Therapeutics operates as a preclinical stage company.

Biotechnology · London$78.7M Series A
PredictImmune
March 2023

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Biopharma · CambridgeGrant
Seldon
March 2023

Seldon is a machine learning deployment platform.

Artificial Intelligence (AI) · London$20.0M Series B
Origami
September 2022

Origami is an intelligent trading and automation software for short term power trading.

Energy · Cambridge$6.2M Venture - Series Unknown

Where Cambridge Innovation Capital invests

Biotechnology12
Medical8
Life Science6
Therapeutics6
Health Care5
Software5

About Cambridge Innovation Capital's portfolio

How many companies has Cambridge Innovation Capital invested in?▸

Cambridge Innovation Capital has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Cambridge Innovation Capital invest in?▸

Cambridge Innovation Capital's top investment sectors include Biotechnology, Medical, Life Science, Therapeutics, Health Care. The firm invests across 35 different industry categories.

What is Cambridge Innovation Capital's largest investment?▸

Among tracked funding rounds, CMR Surgical received $400.0M in a Corporate Round round. Cambridge Innovation Capital's total known invested capital is $1.8B.

What is the average investment size for Cambridge Innovation Capital?▸

Cambridge Innovation Capital's average investment size is $33.8M across its portfolio of 52 companies.

What are Cambridge Innovation Capital's most recent investments?▸

Recent Cambridge Innovation Capital portfolio additions include Microbiotica, Salience Labs, CMR Surgical, TRIMTECH Therapeutics, Undo. These companies were founded in 2020 or later.

Reach the founders behind these 52 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →